Register for Zoom In On Dementia & Alzheimer’s
Register for Zoom In On Dementia & Alzheimer’s
TITLE
The Next Generation of Alzheimer’s Treatments
DATE
Thursday, November 20,, 2025
TIME
1 pm ET (please adjust for your time zone)
SPEAKER(S)
Marwan Noel Sabbagh, MD, FAAN
Join behavioral neurologist Dr. Marwan Sabbagh for an in-depth discussion about emerging Alzheimer’s therapeutics now in late-stage clinical development. Disease-modifying drugs including Anavex Life Science’s oral drug blarcamesine, Roche’s trontinemab, and Eli Lilly’s remternetug will be discussed, along with symptomatic agents such as Axsome’s AXS-05. Learn about clinical studies that are currently or soon-to-be recruiting and how these innovative therapies could shape the future of Alzheimer’s treatment.
Watch Past Episodes
The Gut Microbiome and Alzheimer’s Disease: Understanding the Connection
Join Dr. Beau Ances of Washington University in St. Louis to learn about the emerging science linking gut health and brain health.
U.S. POINTER Study Update: Lifestyle Program Significantly Improves Cognition in Older Adults
Can everyday lifestyle choices really protect your memory? Dr. Laura Baker, professor at Wake Forest University School of Medicine, will share results from the groundbreaking U.S. POINTER trial—the largest study of its kind to test how lifestyle changes impact brain health.
Can GLP-1 Weight Loss Drugs Treat Alzheimer’s?
Recent research suggests that GLP 1 analogs—a class of drugs used to control blood sugar—may also protect brain health, improve memory, and slow neurodegeneration.
Can Brain Tissue Be Regenerated? Inside the ReGenBrain Trial
Can brain tissue be regenerated? Join Roberta Diaz Brinton, PhD, Director of the Center for Innovation in Brain Science at the University of Arizona, to learn about the ReGenBRAIN clinical trial.
Beyond Medication: Non-Pharmacologic Treatments for Dementia
Join us for a conversation with Cleveland Clinic Nevada Medical Director Dr. Dylan Wint on non-pharmacologic approaches to dementia care.
How Focused Ultrasound is Changing Alzheimer’s Treatment
Join Dr. Ali R. Rezai, a leader in neuroscience and neuromodulation, for a live conversation on how focused ultrasound is opening new possibilities in Alzheimer’s research and care.
How Much Forgetfulness is Too Much?
Ronald C. Petersen, MD, PhD, discusses what we know about Alzheimer’s and how we can better understand what it is – and what it isn’t.
Alzheimer’s Research Opportunities: How to Participate
Dr. Michelle Papka gives insights into how to participate in trials that are currently open for enrollment across the US.